INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 136 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $312,000 | -42.2% | 22,600 | -31.9% | 0.01% | -35.7% |
| Q1 2022 | $540,000 | -5.3% | 33,163 | +34.4% | 0.01% | -57.6% |
| Q1 2021 | $570,000 | -38.4% | 24,676 | -34.1% | 0.03% | -46.8% |
| Q4 2020 | $925,000 | +65.2% | 37,453 | +177.2% | 0.06% | 0.0% |
| Q3 2020 | $560,000 | -81.5% | 13,510 | -44.6% | 0.06% | -68.4% |
| Q4 2019 | $3,022,000 | +3.0% | 24,390 | -44.8% | 0.20% | +12.6% |
| Q3 2019 | $2,934,000 | – | 44,200 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |